Compounds > glycolaldehyde
Page last updated: 2024-10-18

glycolaldehyde and Cardiometabolic Syndrome

glycolaldehyde has been researched along with Cardiometabolic Syndrome in 1 studies

Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Unno, Y1
Sakai, M1
Sakamoto, Y1
Kuniyasu, A1
Nagai, R1
Nakayama, H1
Horiuchi, S1

Other Studies

1 other study available for glycolaldehyde and Cardiometabolic Syndrome

ArticleYear
Glycolaldehyde-modified bovine serum albumin downregulates leptin expression in mouse adipocytes via a CD36-mediated pathway.
    Annals of the New York Academy of Sciences, 2005, Volume: 1043

    Topics: 3T3 Cells; Acetaldehyde; Adipocytes; Animals; CD36 Antigens; Cell Culture Techniques; Gene Expressio

2005